|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term bank deposits | ||||||||||||||||||||
| Short-term restricted bank deposits | ||||||||||||||||||||
| Trade receivables, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Other accounts receivable and prepaid expenses | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| NON-CURRENT ASSETS: | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Operating lease right of use assets | ||||||||||||||||||||
| Long-term assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| CURRENT LIABILITIES: | ||||||||||||||||||||
| Trade payables | ||||||||||||||||||||
| Deferred revenues | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other accounts payable and accrued expenses | ||||||||||||||||||||
| Current maturity of long-term loan | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| NON-CURRENT LIABILITIES | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Long-term loan | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total non-current liabilities | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY ** | ||||||||||||||||||||
| Common stock of $0.0001 par value - authorized: 400,000,000 shares; issued and outstanding: 7,341,866 and 6,905,948 shares on June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
